Back to all studies
RecruitingNCT05656469

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

This study is recruiting. It focuses on anxiety and currently lists participation information in Germany, the Netherlands, Romania, Serbia, Spain, the United Kingdom, and the United States.

Anxiety, Schizophrenia, ...BehavioralFrom 16 Years to 70 Years
In plain English

Key information made simple

What is this study testing?

This study is testing whether Personalised medication advice based on pharmacogenetic testing may be useful for people experiencing anxiety.

What would participation involve?

Participants may complete study activities around Personalised medication advice based on pharmacogenetic testing, attend study visits with the research team. The registry lists locations in Germany, in the Netherlands, and in Romania.

Who is it mainly for?

This study appears to be mainly for people with anxiety.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: February 23, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
2,500
Sponsor
Parnassia Groep
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
OTHER
Study phase
Not clearly listed
Locations
United States, United Kingdom, Germany, ...
Age range
From 16 Years to 70 Years
Official registry ID
NCT05656469
Official title
A New Intervention for Implementation of Pharmacogenetics in Psychiatry

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Germany · 2 sites
  • University Hospital Bonn, Department of Psychiatry and Psychotherapy
    Bonn
    Site status: Recruiting
  • Ludwig-Maximilian University, University Hospital, Institute of Psychiatric Phenomics and Genomics (IPPG)
    München
    Site status: Recruiting
Netherlands · 2 sites
  • Parnassia Psychiatric Institute, Department of Psychiatry
    Amsterdam
    Site status: Recruiting
  • Maastricht University, Department of Psychiatry and Neuropsychology
    Maastricht
    Site status: Recruiting
Romania · 1 site
  • Babeş-Bolyai University, Department of Clinical Psychology and Psychotherapy
    Cluj-Napoca
    Site status: Recruiting
Serbia · 1 site
  • University of Belgrade, Faculty of Pharmacy
    Belgrade
    Site status: Recruiting
Spain · 1 site
  • Fundació Clínic per a la Recerca Biomèdica, Department of Psychiatry and Psychology, Hospital Clínic
    Barcelona
    Site status: Recruiting
United Kingdom · 1 site
  • King's College, Institute of Psychiatry, Psychology & Neuroscience
    London
    Site status: Recruiting
United States · 1 site
  • SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences
    Syracuse, New York
    Site status: Not Yet Recruiting

Want help reviewing this study?

Loading the security check...
Study ID: NCT05656469. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring psychotherapy or therapy for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving Personalised medication advice based on pharmacogenetic testing. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with anxiety; age range: From 16 Years to 70 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Parnassia Groep, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me